EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients

Peter Nyvlt, Friederike S Schuster, Jana Ihlow iD, Patrick Heeren, Claudia Spies, Josephine Hiesgen, Thomas Schenk, Ann-Christin von Brünneck, Jörg Westermann, Frank M Brunkhorst, Paul La Rosée, Gritta Janka und 2 weitere

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14185 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Peter Nyvlt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and…. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Critical Illness, Ferritins, Biomarkers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Charité-Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferritin is an established biomarker in the diagnosis of secondary hemophagocytic lymphohistiocytosis (HLH), which is diagnosed by the HLH‐2004 criteria. Among these criteria, detection of hemophagocytosis through invasive procedures may delay early life saving treatment. Our aim was to investigate the value of hemophagocytosis in diagnosing HLH in critically ill patients.

Methods

In this secondary analysis of a retrospective observational study, we included all patients aged ≥18 years and admitted to any adult ICU at Charité—Universitätsmedizin Berlin between January 2006 and August 2018, who had hyperferritinemia (≥500 μg/L) and underwent bone marrow biopsy during their ICU course.

Results

Two hundred fifty‐two patients were included, of whom 31 (12.3%) showed hemophagocytosis. In multivariable logistic regression analysis, maximum ferritin was independently associated with hemophagocytosis. By removing hemophagocytosis from HLH‐2004 criteria and HScore, prediction accuracy for HLH diagnosis was only marginally decreased compared to the original scores.

Conclusions

Our results strengthen the diagnostic value of ferritin and underline the importance of considering HLH diagnosis in patients with high ferritin but only four fulfilled HLH‐2004 criteria, when hemophagocytosis was not assessed or not detectable. Proof of hemophagocytosis is not required for a reliable HLH diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticCritical IllnessFerritinsBiomarkersHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultBone Marrow

Stichwörter der Autor:innen

HLH‐2004HScorebone marrow biopsycritically ill patientsferritinhemophagocytic lymphohistiocytosis (HLH)hemophagocytic syndrome (HS)hemophagocytosismacrophage activation syndrome (MAS)mortality

Substanzen

FerritinsBiomarkers

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM, CVK), Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Berlin, Germany.
  • Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Hematology and Oncology, Universitätsklinikum Jena, Jena, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
  • Center for Clinical Studies, Department of Anesthesiology and Intensive Care Medicine, Universitätsklinikum Jena, Jena, Germany.

ORCID-Profile: Jana Ihlow, Gunnar Lachmann

Förderung

  • Charité-Universitätsmedizin Berlin
  • Charité – Universitätsmedizin Berlin

Zitieren

APA

Nyvlt, P., Schuster, F. S., Ihlow, J., Heeren, P., Spies, C., Hiesgen, J., Schenk, T., von Brünneck, A. C., Westermann, J., Brunkhorst, F. M., La Rosée, P., Janka, G., Lachmann, C., & Lachmann, G. (2024). Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients. European Journal of Haematology. https://doi.org/10.1111/ejh.14185

Vancouver

Nyvlt P, Schuster FS, Ihlow J, Heeren P, Spies C, Hiesgen J, et al. Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients. European Journal of Haematology. 2024. doi:10.1111/ejh.14185

BibTeX
@article{Nyvlt2024,
  author = {Nyvlt, Peter and Schuster, Friederike S and Ihlow, Jana and Heeren, Patrick and Spies, Claudia and Hiesgen, Josephine and Schenk, Thomas and von Brünneck, Ann-Christin and Westermann, Jörg and Brunkhorst, Frank M and La Rosée, Paul and Janka, Gritta and Lachmann, Cornelia and Lachmann, Gunnar},
  title = {Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14185}
}
Kostenlos starten →